Biocon Limited (BIOCON) announced that its Pertuzumab biosimilar secured EMA CHMP approval, marking a significant milestone in expanding access to HER2-posit.
Biocon Limited (BIOCON) secures a 10-year supply contract for Pertuzumab in Brazil, marking a significant milestone in advancing HER2-positive breast cancer.
Dishman Carbogen Amcis Limited (DCAL) reports Q1FY27 results with net revenue dipping 4.29%, driven by CDMO segment decline.
Praj Industries Limited reports a 27% YoY increase in net profit and ₹35,280 Cr revenue for Q1 FY27, showcasing strong financial performance.
Zota Health Care Limited (ZOTA) reports a 67.59% YoY revenue growth in Q1FY27, reaching ₹17,360.23 lakhs, driven by network expansion.
Praj Industries Limited (PRAJIND) reports Q1 FY27 results with revenue up 12% and PAT at Rs. 116 million.
Supriya Lifescience Limited (NSE: SUPRIYA) drops 6% intraday to ₹858.65, showing a breakdown in trendline status in the Healthcare » Biotechnology sector.
Anthem Biosciences Limited (NSE: ANTHEM) stock cleared its 6M resistance trendline and is up 5% intraday at ₹896.8.
Biocon Limited (BIOCON) reports Q1 FY27 results with a 9% revenue increase, driven by strong biosimilars performance.
Biocon Limited (BIOCON) reports a 9% rise in total income to Rs 4,391 Cr for Q1 FY27, driven by strong Biopharma growth.